Navigation Links
Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
Date:3/6/2008

IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular patient temperature management therapies, announced it will release its fourth quarter and year-end 2007 financial results on March 13, 2008, following the market close.

A conference call and webcast to review the results will follow the same day at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). This call will be open to all interested parties live via the conference lines listed below. A live webcast will be available on the Investor Relations section of the company's website http://www.alsius.com at 1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the conference call concludes, an archived version of the webcast will be available on the site, and a telephone replay of the call will be available via the dial-in numbers listed below.

Date: Thursday, March 13, 2008

Live call: Callers within the U.S. may dial 877-440-5791. International

callers can dial 719-325-4879. No passcode is necessary for the

live call.

Webcast: A webcast will be available live via the Investor Relations

section of the company's website http://www.alsius.com at

1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the

conference call concludes, an archived version of the webcast

will be available on the site.

Replay: Telephone replay will be available beginning 90 minutes after

the call concludes, from March 13 through March 31, 2008. For

the U.S. and Canada, dial 888-203-1112; conference

identification number 3423016. International callers, dial

719-457-0820; conference identification number 3423016.

About Alsius

Alsius, headquartered in Irvine, CA, is a commercial-stage medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients. For more information, visit http://www.alsius.com .


'/>"/>
SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
2. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
3. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
4. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
5. Pharmion Corporation Announces 2007 Operating Results
6. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
7. VLST Corporation Announces Board and Executive Management Appointments
8. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
9. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
10. LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
11. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 2017 , ... AxioMed will be presenting its viscoelastic cervical ... Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits ... the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... ... 20, 2017 , ... G&L Scientific Inc, a leading provider ... ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and ... This is the latest step in G&L’s expansion of its global clinical consulting ...
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... our ongoing endeavors to bring to market a pioneering medical device for the ... has signed an engagement contract with Emergo, a global regulatory consultancy that helps ...
(Date:1/21/2017)... BOULDER, Colo. , Jan. 20, 2017 ... ("Bioptix" or the "Company"), announced that on January 14, ... a plan under which the Company will terminate certain ... subsidiary, Bioptix Diagnostics, Inc.  The Company commenced terminations on ... completed within 30 days.  The Company may pay severance ...
Breaking Biology Technology:
(Date:1/11/2017)... 11, 2017 Intoxalock, a leading ignition interlock ... of its patent-pending calibration device. With this new technology, ... securely upload data logs and process repairs at service ... "Fighting drunk driving through the application of cutting-edge ... large, but also for the customer who can get ...
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
Breaking Biology News(10 mins):